Tofranil (Imipramine) – Patient-Friendly Medicine Information (Australia)

Tofranil contains the active ingredient imipramine, a medicine in the class of antidepressants called tricyclic antidepressants (TCAs). It has been used for decades to treat certain mental health conditions and, in some cases, to help with specific physical symptoms such as bedwetting (in children). This page explains how Tofranil works, how it’s used, what to expect, and key safety information relevant for people in Australia.

Always follow the advice of your healthcare professional. Medicines can differ in suitability depending on your medical history, other medicines, and individual risk factors.

Basic product information

How Tofranil works (mechanism of action)

Imipramine helps improve mood and certain behavioural symptoms by affecting chemical messengers in the brain. The best-understood mechanism involves increasing the availability of neurotransmitters such as:

• Noradrenaline (norepinephrine)
• Serotonin

It does this by influencing re-uptake (reabsorption) of neurotransmitters, helping them remain active in the brain for longer. In addition, imipramine has effects on several other receptors (including those involved in sleep, anxiety, and pain processing), which contributes to both its therapeutic effects and side effects.

Pharmacokinetics (how the body processes it)

Pharmacokinetics explains what the body does to a medicine—absorption, distribution, metabolism, and excretion. While individual results vary, the following are typical features:

• Absorption: Imipramine is absorbed after oral dosing. Food and timing can influence how quickly it reaches peak blood levels in some people.
• Distribution: It distributes throughout the body and can cross into the brain and other tissues.
• Metabolism: Imipramine is mainly metabolised by the liver (notably involving enzymes such as CYP pathways). Some people may experience higher levels if they have liver impairment or use interacting medicines.
• Elimination: The medicine and its metabolites are cleared from the body primarily through the kidneys and urine. Active metabolites may persist longer than the parent drug.

Because TCAs can accumulate and affect heart rhythm in some circumstances, careful dosing and monitoring are important, especially when starting or increasing doses.

Typical use in Australia

Tofranil is used for:

• Depressive illness (including when symptoms are persistent and do not respond adequately to other options).
• Enuresis (bedwetting) in children and adolescents in selected situations where appropriate. Treatment is usually considered after other causes have been assessed and non-medicine approaches have been tried.

Use for bedwetting is typically considered in a structured plan and may involve specific stopping and monitoring routines agreed with your doctor.

When to take it (timing and routines)

Timing depends on the condition being treated and how you respond to side effects such as drowsiness. Many people find that taking imipramine in the evening or before bedtime is helpful if it causes sleepiness.

General timing principles:

• Depression: Doses are often given once daily, sometimes in the evening, depending on sedation and your clinician’s plan.
• Enuresis (bedwetting): Dosing is commonly aligned with the bedtime period (as directed by your doctor).
• Try to stay consistent: Take your dose at the same time each day.
• If you miss a dose: Follow your clinician’s instructions or the medicine label. In general, do not take a double dose to make up for a missed dose.

If you experience significant drowsiness, dizziness, or palpitations after dosing, contact your healthcare professional promptly.

Food interactions

Food may affect how quickly imipramine is absorbed in the stomach and can slightly change the timing of peak effects. Most people can take it with or without food, but consistency is helpful.

Practical guidance:

• If you feel nausea or stomach upset, taking imipramine with food may help.
• Avoid abrupt changes in meal patterns when your dose is being adjusted (your clinician may want to know what changed).

Alcohol and medicine interactions

Imipramine can cause drowsiness and affect alertness. Alcohol can worsen these effects. Combining alcohol with Tofranil can increase the risk of impaired coordination, falls, and greater sedation.

Alcohol

• Recommendation: It’s best to avoid alcohol or use it only with explicit clinician approval.
• Do not drive or operate machinery if you feel sleepy, slowed, or dizzy.

Important medicine interactions

Interactions can raise the risk of side effects or reduce effectiveness. Always provide your complete list of medicines (including over-the-counter products, vitamins, and herbal supplements) to your healthcare professional.

Examples of medicines that may interact with imipramine:

• Other antidepressants (especially those affecting serotonin/noradrenaline pathways)
• Monoamine oxidase inhibitors (MAOIs) – commonly contraindicated with TCAs
• Medicines that affect heart rhythm or lower the seizure threshold
• Medicines metabolised by liver enzymes (some can increase Tofranil levels)
• Strong anticholinergic medicines (may increase constipation, dry mouth, blurred vision, urinary retention)
• Sleep medicines, sedatives, opioids – may increase sedation and impairment

If you start any new medicine while taking Tofranil, check with a pharmacist or clinician to confirm it’s safe with imipramine.

Indications and who may be eligible

Tofranil is indicated for specific conditions. Eligibility depends on your age, diagnosis, symptom severity, and safety considerations.

Indications

• Depressive illness: When a clinician determines a TCA is appropriate for your situation.
• Enuresis (bedwetting): For selected children and adolescents meeting criteria, typically as part of a broader plan.

People who need extra caution

Imipramine may require careful monitoring or may not be suitable for some people, for example:

• People with a history of heart rhythm problems or certain cardiac diseases
• People with seizure disorders or increased seizure risk
• People with urinary retention or significant prostate problems (for males)
• People with glaucoma (especially narrow-angle glaucoma)
• People with liver impairment
• People taking multiple medicines that interact with TCAs

Dosing: general principles (do not use this as a personalised instruction)

Dosing is individual. Your clinician will choose a starting dose and adjust slowly based on response and tolerability. Imipramine is a medicine where small dose changes can affect both benefits and side effects.

Important dosing guidance:

• Start low, go slow: clinicians typically begin with a lower dose and adjust gradually.
• Follow the label exactly: do not change the dose or stop suddenly without medical advice.
• Evening dosing: if sedation occurs, doses are commonly scheduled in the evening.
• Bedwetting regimens: the timing and duration can differ from depression treatment and are often periodically reviewed.

If you need help understanding your regimen, check the instructions on your medicine packaging and ask your pharmacist.

Safety profile: common side effects and what to watch for

Like all medicines, Tofranil can cause side effects. Many are mild and improve as your body adapts, but some require urgent attention. The safety profile varies from person to person.

Common side effects

• Drowsiness or fatigue
• Dizziness (especially when standing)
• Dry mouth
• Blurred vision
• Constipation
• Increased sweating
• Weight changes (some people gain weight)
• Reduced appetite or, conversely, increased appetite
• Nausea

Serious side effects (seek urgent medical help)

Contact emergency services or seek urgent medical attention if you experience signs of a serious reaction, such as:

• Chest pain, fainting, or a very fast/irregular heartbeat
• Severe dizziness, collapse, or symptoms suggesting a significant drop in blood pressure
• Seizures
• Allergic reaction (swelling of face/lips, hives, trouble breathing)
• Confusion, high fever, severe agitation, muscle stiffness, or signs that may resemble a serious drug reaction

Suicidal thoughts and mood changes

Antidepressant medicines can affect mood and behaviour, particularly at the beginning of treatment or after dose changes. It’s important to watch for worsening depression, new or increased anxiety, agitation, or any thoughts of self-harm—especially during the first weeks.

• Seek immediate help if you or someone else notices concerning changes.
• In Australia, you can contact Lifeline on 13 11 14 or 000 in emergencies.

Practical use tips (how to get the best and safest results)

• Give it time: antidepressant effects are usually gradual. Don’t judge the medicine too early.
• Track symptoms: keep a simple daily note of mood, sleep, appetite, side effects, and bedwetting patterns.
• Rise slowly: if you feel light-headed, stand up gradually to reduce dizziness.
• Constipation prevention: drink water, eat fibre, and consider discussing stool softeners with your pharmacist if needed.
• Hydration and oral care: dry mouth can be managed with frequent sips of water, sugar-free chewing gum, and good oral hygiene.
• Driving and machines: avoid driving until you know how Tofranil affects you.
• Do not stop suddenly: stopping abruptly can lead to withdrawal-like symptoms and mood changes. Ask for a safe taper plan.

Stopping and missed doses

If you miss a dose, take it as directed on the label or by your clinician. In general, avoid doubling up. If you’re thinking about stopping, talk to a healthcare professional before changing your routine.

Dose changes and discontinuation should be planned carefully because of the potential for symptom relapse and uncomfortable effects if stopped too quickly.

Alternative options

Depending on what you’re treating, your clinician may consider alternatives to imipramine. These may include:

• Other antidepressants: SSRIs, SNRIs, and other classes
• Psychological therapies: for depression, talking therapies may be used alone or alongside medication
• For bedwetting: behavioural strategies (fluid timing, bladder training), enuresis alarms, or other medicine options as appropriate
• Specialist assessment: if symptoms persist or there are underlying causes to address

Your “best alternative” depends on your diagnosis, age, medical history, and side effect tolerance. Ask your pharmacist or doctor for options suitable for you.

Market and legal context for Australia

In Australia, medicines are regulated under the national medicines and poisons framework. Availability depends on medicine scheduling, which reflects safety considerations. Imipramine-containing products are subject to Australian regulatory requirements and are provided through appropriate healthcare channels.

For online pharmacies, reputable suppliers must comply with applicable Australian laws and verification requirements. This includes ensuring that medication is supplied responsibly and that appropriate patient information is provided.

Recent guidance and monitoring considerations

Ongoing guidance in Australia emphasises safe use of antidepressants, including:

• Monitoring early treatment: watching for behavioural changes, sleep changes, agitation, or worsening mood
• Assessing risk factors: reviewing heart rhythm risks, interactions, and seizure risk before and during treatment
• Checking medicine interactions: especially when starting or stopping medicines that may increase TCA levels or affect heart rhythm
• Individualised dosing: tailoring dose to symptoms and tolerability rather than a one-size-fits-all approach

If you have concerns, ask your healthcare professional what specific monitoring applies to your situation (for example, symptom reviews and any relevant health checks).

Delivery and availability (online pharmacy)

Availability of Tofranil (imipramine) may vary by supplier and by formulation strength. Online pharmacies in Australia typically offer:

• Secure ordering: with patient information and medicine details provided before dispatch
• Delivery options: standard and sometimes express delivery depending on location
• Packaging for safety: medicines are generally packed to prevent damage in transit

If you need your medicine urgently, choose an appropriate delivery option and contact customer support for stock and dispatch timeframes.

FAQ

1) How long does Tofranil take to work?

For depression, some people notice changes within the first 1–2 weeks, but fuller improvement often takes several weeks. Don’t stop early if you feel only minor changes—discuss progress with your clinician.

2) Why do I feel drowsy after taking imipramine?

Imipramine can cause sedation. Many people take their dose in the evening and avoid driving or hazardous tasks until they know how it affects them.

3) Can I take Tofranil with food?

In many cases, it can be taken with or without food. If food reduces nausea or stomach upset, taking it with a meal can help. Try to keep your routine consistent.

4) Is it safe to drink alcohol while on Tofranil?

Alcohol can worsen drowsiness and impair judgement. It’s generally best to avoid alcohol or follow specific advice from your healthcare professional.

5) What should I do if I miss a dose?

Check the instructions on your medicine label or ask your pharmacist. Often, you should take the next dose at the usual time and avoid doubling up.

6) What are the most important interactions?

Interactions vary, but key areas include other antidepressants (particularly MAOIs), medicines that affect heart rhythm, sedatives/sleep medicines, and medicines that raise imipramine levels in the body. Always check with your pharmacist if starting or stopping any medicines.

7) Can I stop Tofranil suddenly?

Stopping abruptly is not recommended. Your clinician can help you taper safely to reduce the chance of withdrawal-like symptoms and relapse.

8) Does Tofranil cause weight changes?

Some people experience weight gain or appetite changes. If this becomes a concern, discuss it with your clinician—there are practical strategies and alternative options.

9) Is Tofranil used for bedwetting?

Yes, in selected cases for enuresis (bedwetting) in children and adolescents, typically as part of a structured plan and with agreed monitoring. Eligibility and duration are determined by a clinician.

10) When should I seek urgent medical help?

Seek urgent help if you notice severe side effects such as fainting, chest pain, severe irregular heartbeat, seizure, difficulty breathing, or signs of a serious allergic reaction.

Last notes (important)

This information is intended to help you understand Tofranil (imipramine) and prepare questions for your healthcare team. It does not replace personalised medical advice. If you have any concerns about side effects, interactions, or how to take your medicine safely, speak to a pharmacist or clinician.